Ingrid Klingmann

835 total citations
43 papers, 452 citations indexed

About

Ingrid Klingmann is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ingrid Klingmann has authored 43 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 14 papers in Economics and Econometrics and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ingrid Klingmann's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmaceutical studies and practices (8 papers) and Innovations in Medical Education (6 papers). Ingrid Klingmann is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmaceutical studies and practices (8 papers) and Innovations in Medical Education (6 papers). Ingrid Klingmann collaborates with scholars based in Germany, Netherlands and United Kingdom. Ingrid Klingmann's co-authors include Amy Hunter, David Haerry, Manfred Wargenau, Karen Facey, E. E. Ohnhaus, Victoria Thomas, Wilhelm Kirch, J. Pabst, Berthold Langguth and Martin Walger and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

Ingrid Klingmann

39 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Klingmann Germany 12 135 105 104 65 52 43 452
Courtney I. Jarvis United States 10 116 0.9× 35 0.3× 53 0.5× 43 0.7× 40 0.8× 17 483
Anna Cargill United Kingdom 7 177 1.3× 96 0.9× 24 0.2× 133 2.0× 11 0.2× 8 682
Lily Lai United Kingdom 9 81 0.6× 62 0.6× 28 0.3× 85 1.3× 37 0.7× 26 645
Samantha Roberts United Kingdom 12 57 0.4× 52 0.5× 124 1.2× 56 0.9× 15 0.3× 18 547
Erica C.G. van Geffen Netherlands 14 42 0.3× 99 0.9× 103 1.0× 60 0.9× 32 0.6× 20 580
Tara Schmidlen United States 17 130 1.0× 78 0.7× 72 0.7× 97 1.5× 39 0.8× 36 727
Wesley Nuffer United States 17 168 1.2× 166 1.6× 39 0.4× 39 0.6× 36 0.7× 52 1.2k
Katrina Perehudoff Netherlands 15 59 0.4× 66 0.6× 161 1.5× 107 1.6× 13 0.3× 45 536
Eckhard Nagel Germany 14 80 0.6× 127 1.2× 41 0.4× 18 0.3× 44 0.8× 92 599
Laragh Gollogly Belgium 11 72 0.5× 56 0.5× 34 0.3× 54 0.8× 35 0.7× 23 385

Countries citing papers authored by Ingrid Klingmann

Since Specialization
Citations

This map shows the geographic impact of Ingrid Klingmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Klingmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Klingmann more than expected).

Fields of papers citing papers by Ingrid Klingmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Klingmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Klingmann. The network helps show where Ingrid Klingmann may publish in the future.

Co-authorship network of co-authors of Ingrid Klingmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Klingmann. A scholar is included among the top collaborators of Ingrid Klingmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Klingmann. Ingrid Klingmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klein, Joshua P., Thijs van Iersel, Daniel H. de Vries, Yves Donazzolo, & Ingrid Klingmann. (2025). Healthy participant engagement in early clinical trials: results from the European EUFEMED survey. Frontiers in Pharmacology. 16. 1540948–1540948.
3.
Klingmann, Ingrid, et al.. (2024). Publishing clinical trial results in plain language: a clash of ethical principles?. Current Medical Research and Opinion. 40(3). 493–503. 2 indexed citations
4.
Drinkwater, Jessica, Michelle Farr, Gary Hickey, et al.. (2024). Series: Public engagement with research. Part 3: Sharing power and building trust through partnering with communities in primary care research. European Journal of General Practice. 30(1). 2328707–2328707. 1 indexed citations
5.
6.
7.
8.
Wargenau, Manfred, et al.. (2022). A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population. Therapeutic Innovation & Regulatory Science. 56(6). 903–909. 11 indexed citations
9.
Klingmann, Ingrid, et al.. (2022). Veränderungen durch die neue EU-Verordnung 536/2014 zu klinischen Prüfungen aus Patientensicht. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 66(1). 68–74. 1 indexed citations
10.
Sessa, Cristiana, Caecilia Schmid, Angela Tolotti, et al.. (2021). The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project. Frontiers in Medicine. 8. 795659–795659. 2 indexed citations
11.
Criscuolo, Domenico, et al.. (2020). The Specialist in Medicines Development (SMD) as a Vocational Program in Pharmaceutical Medicine: The Japanese and Italian Experience. Frontiers in Pharmacology. 11. 62–62. 1 indexed citations
12.
Negrouk, Anastassia, et al.. (2020). Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality. Frontiers in Medicine. 7. 585722–585722. 5 indexed citations
13.
Stonier, Peter, Honorio Silva, Alan S. Boyd, et al.. (2020). Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and Training. Frontiers in Pharmacology. 11. 282–282. 11 indexed citations
14.
Khalil, Feras, Holger Schwender, Michiel Dalinghaus, et al.. (2019). Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European survey. BMJ Paediatrics Open. 3(1). e000365–e000365. 11 indexed citations
15.
Haerry, David, et al.. (2018). EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes. Frontiers in Medicine. 5. 230–230. 40 indexed citations
16.
Bortel, Luc Van, Hildegard Sourgens, Kerstin Breithaupt‐Grögler, et al.. (2018). EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management. Frontiers in Pharmacology. 8. 901–901. 2 indexed citations
17.
Dalinghaus, Michiel, Michael Burch, András Szatmári, et al.. (2017). Question 1: How safe are ACE inhibitors for heart failure in children?. Archives of Disease in Childhood. 103(1). 106.1–109. 5 indexed citations
18.
Calsteren, Kristel Van, Ksenija Geršak, Ingrid Klingmann, et al.. (2016). Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG). European Journal of Obstetrics & Gynecology and Reproductive Biology. 201. 211–214. 13 indexed citations
19.
Silva, Honorio, Peter Stonier, Fritz R. Bühler, et al.. (2013). Core competencies for pharmaceutical physicians and drug development scientists. Frontiers in Pharmacology. 4. 105–105. 38 indexed citations
20.
Wurst, W, et al.. (1989). Effect of urapidil on steady-state serum digoxin concentration in healthy subjects. European Journal of Clinical Pharmacology. 37(2). 193–194. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Courtney I. Jarvis Breakdown of academic impact, for papers by Anna Cargill Breakdown of academic impact, for papers by Lily Lai Breakdown of academic impact, for papers by Samantha Roberts Breakdown of academic impact, for papers by Erica C.G. van Geffen Breakdown of academic impact, for papers by Tara Schmidlen Breakdown of academic impact, for papers by Wesley Nuffer Breakdown of academic impact, for papers by Katrina Perehudoff Breakdown of academic impact, for papers by Eckhard Nagel Breakdown of academic impact, for papers by Laragh Gollogly
Rankless by CCL
2026